Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment-Reference-Cited by-同舟云学术

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment

Published:2018-05-24 Issue: Volume:6 Page:
ISSN:2296-2646
Container-title:Frontiers in Chemistry
language:
Short-container-title:Front. Chem.

Author:

Coimbra Judite R. M.,Marques Daniela F. F.,Baptista Salete J.,Pereira Cláudia M. F.,Moreira Paula I.,Dinis Teresa C. P.,Santos Armanda E.,Salvador Jorge A. R.

Publisher

Frontiers Media SA

Subject

General Chemistry

Reference82 articles.

1. Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: design, synthesis and SAR analysis;Azimi;Eur. J. Med. Chem.,2017

2. Drugs in clinical trials for Alzheimer's Disease: the major trends;Bachurin;Med. Res. Rev,2017

3. BACE1 physiological functions may limit its use as therapeutic target for Alzheimer's Disease;Barão;Trends. Neurosci,2016

4. Specific inhibition of β-secretase processing of the alzheimer disease amyloid precursor protein;Ben Halima;Cell Rep,2016

5. 5-amino-oxazepine and 5-amino-thiazepine compounds as β-secretase antagonists and methods of use: patent highlight;Blass;ACS Med. Chem. Lett,2012

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3β/Aβ aggregation inhibitor and anti-Alzheimer’s agent;Bioorganic Chemistry;2024-12

2. Emerging paradigms in Alzheimer's therapy;European Journal of Pharmacology;2024-10

3. Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer’s Disease;Central Nervous System Agents in Medicinal Chemistry;2024-08

4. BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects<sup>† </sup>;Global Health & Medicine;2024-06-30

5. BACE1 Inhibitors for Alzheimer’s Disease: Current Challenges and Future Perspectives;Journal of Alzheimer's Disease;2024-06-22